下颌下腺恶性肿瘤手术切缘阳性:机构与实践差异
基于美国国家癌症数据库2004至2014年1150例接受原发手术切除的下颌下腺癌患者,切缘阳性率为41.0%。晚期T分期、腺样囊性癌组织学和非学术机构治疗与切缘阳性风险升高相关,术前诊断性活检与风险降低相关。切缘阳性与总生存期降低独立相关,5年总生存率58%对69%。
要点
- 下颌下腺癌全国队列切缘阳性率为41.0%。
- T3期比值比3.04、T4a期2.89,腺样囊性癌1.54,非学术机构1.41,均与切缘阳性风险升高相关。
- 术前诊断性活检比值比0.72,与切缘阳性风险降低相关。
核心结论
- 下颌下腺癌全国切缘阳性率为41.0%。
- 术前活检和在学术机构治疗独立降低切缘阳性风险,切缘阳性独立与总生存期降低相关。
- 下颌下腺癌切缘阳性率可考虑作为医疗质量基准。
研究设计与样本
- 回顾性队列研究,纳入美国国家癌症数据库2004至2014年诊断并接受原发手术切除的下颌下腺癌患者。
- 共纳入1150例患者,来自Commission on Cancer认证医院。
- 采用单变量和多变量逻辑回归分析切缘阳性的相关因素,采用Kaplan-Meier曲线和Cox比例风险回归分析切缘状态与总生存期的关联。
主要发现
- 切缘阳性率为41.0%。
- 晚期T分期与切缘阳性风险升高相关:T3期比值比3.04(P<.001),T4a期比值比2.89(P<.001),均以T1期为参照。
- 腺样囊性癌组织学比值比1.54(P=.020),非学术机构治疗比值比1.41(P=.008),均与切缘阳性风险升高相关。
- 术前诊断性活检比值比0.72(P=.014),与切缘阳性风险降低相关。
- 控制患者、肿瘤和治疗因素后,切缘阳性与总生存期降低相关:5年总生存率58%对69%(P<.001),风险比1.49(P=.001)。
关键数值与推荐
- 切缘阳性率41.0%。
- T3期比值比3.04(P<.001),T4a期比值比2.89(P<.001),均以T1期为参照。
- 腺样囊性癌组织学比值比1.54(P=.020)。
- 非学术机构治疗比值比1.41(P=.008)。
- 术前诊断性活检比值比0.72(P=.014)。
临床怎么用
- 作者认为下颌下腺癌切缘阳性率可考虑作为医疗质量基准。
- 原文未据此给出其他临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Identify positive margin rate in a national cohort of patients with submandibular carcinoma, identify predictors of positive margins, and associate margins with overall survival. STUDY DESIGN: Retrospective cohort. SETTING: Commission on Cancer-accredited hospitals. SUBJECTS AND METHODS: We included patients in the National Cancer Database from 2004 to 2014 who were diagnosed with submandibular carcinoma and underwent primary surgical resection. We determined the rate of positive surgical margins and associated patient, tumor, and treatment factors with positive margins via univariable and multivariable logistic regression analysis. We associated margin status with overall survival by Kaplan-Meier curve and Cox proportional hazards regression. RESULTS: We identified 1150 patients with submandibular malignancy undergoing surgical resection. Positive margin rate was 41.0%. Increased odds of positive margins were seen in patients with advanced T stage (vs T1, T3: odds ratio [OR] = 3.04, P < .001; T4a: OR = 2.89, P < .001), adenoid cystic carcinoma histology (OR = 1.54, P = .020), and those treated at nonacademic facilities (OR = 1.41, P = .008). Patients who underwent a preoperative diagnostic biopsy had decreased odds of positive margins (OR = 0.72, P = .014). Positive margins were associated with reduced overall survival (58% vs 69% 5-year overall survival, P < .001; hazard ratio = 1.49, P = .001) when controlling for patient, tumor, and management factors. CONCLUSIONS: The national positive margin rate of submandibular carcinoma is 41.0%. Preoperative biopsy and treatment at academic institutions independently decreased the risk of positive margins, and positive margins were independently associated with diminished overall survival. Positive margin rate for submandibular carcinoma may be considered a benchmark for quality of care.
引用
- Benchetrit L, Morse E, Judson BL, et al. Positive Surgical Margins in Submandibular Malignancies: Facility and Practice Variation. Otolaryngol Head Neck Surg. 2019. PMID: 31159649. doi:10.1177/0194599819852094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。